CEACAM5 and neoplasm: Three of five patients demonstrated marked tumour regression withunexpectedly long survival (16 months in two patients and one still alive at 15 months).Carcinoembryonic antigen (CEA) levels decreased to almost normal in four patients who had initiallyhigh levels.